Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords

Pieris Pharmaceuticals GAAP EPS of -$0.71 beats by $0.17, revenue of $31.41M beats by $5.97M

Mar. 01, 2022 7:18 AM ETPieris Pharmaceuticals, Inc. (PIRS)By: Gaurav Batavia, SA News Editor
  • Pieris Pharmaceuticals press release (NASDAQ:PIRS): FY GAAP EPS of -$0.71 beats by $0.17.
  • Revenue of $31.41M (+7.1% Y/Y) beats by $5.97M.

Recommended For You

Comments

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.